New molecule maps cerebrovascular system

A peptide is capable of binding to the blood-brain barrier that protects the central nervous system and could help create novel imaging tests to diagnose Alzheimer’s and Parkinson’s.

Leave a Reply

Your email address will not be published. Required fields are marked *